News
April 2, 2020
Promising results from first clinical study
Medvasc has conducted the first clinical study with the Solutio, the results are positive and we hope to proceed with more tests to verify the results within short. Read more here…
December 19, 2019
Medvasc raises SEK 3m
Through a directed new share issue Medvasc receives SEK 3M with the purpose of conducting the first clinical study. in conjunction with the financing round Mats Nilsson from MAQS takes the position as Chairman and the entrepreneur Magnus Olsson also becomes a member of the Board. Read more here…
April 2, 2019
Featured in LSX list of top 50 nordic startups
LSX Nordic Congress – a life science investment event taking place at Nasdaq’s Stockholm offices on August 28-29 (2019). An event with 200-250 stakeholders such as investors or CEO´s. Before the event, LSX put together a list with the top 50 Nordic startups – which all are invited. Among…
March 21, 2019
Vinnova IP Strategy grant
Medvasc AB has been granted funding from Vinnova 90.000 SEK supporting ”IP Strategy regarding Solutio: A new medical device for the treatment of varicose veins”…
November 20, 2018
SWE-Life for EIC pilot grant
Medvasc AB has been granted funding from SWE-Life 100.000 SEK for the project “Solutio-Improved varicose vein surgery via new medical device “in the framework of the EIC pilot grant preparation Horizon2020, SME instruments phase 2 Read more about the grant: https://swelife.se/projekt/stod-for-att-soka-eic-pilot/…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice
